A pilot study saw that 80% of participants quit smoking after one dose of psilocybin and research on 51 cancer patients showed the drug decreased anxiety and depression in 80% of those tested.
Read moreMovement to Decriminalize Magic Mushrooms
As cities decriminalize psychedelic fungi, advocates work to legalize statewide. Here’s an update.
Read moreLegal Issues with Psilocybin
While decriminalized in Denver, Colorado and Oakland, California, magic mushrooms are not legal for recreational use anywhere in the United States.
Read moreMagic Mushroom Nasal Spray
A ‘magic mushroom’ nasal spray has been designed to make microdosing easier for people trying to treat PTSD or depression. An Oregon company has developed a magic mushroom nasal spray in Jamaica – where psilocybin is legal – for controlled, metered-dosing known as ‘microdosing’.
Read morePsilocybin Therapy for Major Depression
The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).
Read morePsilocybin Research Update
Keep reading for an in-depth update on psilocybin research.
Read moreMeditation and Psilocybin
This research takes a look at what happens when meditators take psilocybin.
Read moreThe Commercialization of Psilocybin
Food for thought. What happens when psychedelics become a business opportunity?
Read moreLegalizing Psychedelic Mushrooms
Michael Pollan takes a look at the pros and cons of legalizing psychedelic mushrooms, and the potential benefits and risks of taking them.
Read moreSub-Acute Effects of Psilocybin
This research looks at the sub-acute effects of psilocybin on empathy, creative thinking and well-being.
Read more